StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) stock

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)

Close on Nov 13, 2026Market cap $5.33MP/E –Yield –

Intelligent Bio Solutions gross margin

Gross margin is gross profit as a percentage of revenue.

Intelligent Bio Solutions's gross margin for the twelve months ending Sep 30, 2026 was 50.9%. For fiscal 2026 it was 48.6%, against 40.8% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202648.6%+7.8
FY2025Jun 30, 202540.8%−5.0
FY2024Jun 30, 202445.8%+19.8
FY2023Jun 30, 202326.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202654.5%+7.8
Q4 FY2026CQ2 2026Jun 30, 202646.8%+7.1
Q3 FY2026CQ1 2026Mar 31, 202650.5%+3.6
Q2 FY2026CQ4 2025Dec 31, 202551.3%+14.5
Q1 FY2026CQ3 2025Sep 30, 202546.6%+6.9
Q4 FY2025CQ2 2025Jun 30, 202539.8%−174.3
Q3 FY2025CQ1 2025Mar 31, 202546.8%+27.2
Q2 FY2025CQ4 2024Dec 31, 202436.7%+15.0
Q1 FY2025CQ3 2024Sep 30, 202439.8%+14.1
Q4 FY2024CQ2 2024Jun 30, 2024214.1%+202.9
Q3 FY2024CQ1 2024Mar 31, 202419.7%+12.4
Q2 FY2024CQ4 2023Dec 31, 202321.7%−46.7
Q1 FY2024CQ3 2023Sep 30, 202325.6%–
Q4 FY2023CQ2 2023Jun 30, 202311.2%–
Q3 FY2023CQ1 2023Mar 31, 20237.2%–
Q2 FY2023CQ4 2022Dec 31, 202268.4%–

More Intelligent Bio Solutions figures

See a number that looks wrong?